The drugs that are getting a lot of attention are a class of medications called GLP-1 agonists.

目前备受关注物是一类被称为GLP-1受体动物。

The Food and Drug Administration hasn't approved GLP-1 agonists to be used for addiction.

食品品监督管理局尚未批准 GLP-1 动用脱瘾。

The partisan agonists are not wrong about the significance of the moment.

两党内部反应动那部分人对这个时刻重要性理解并无不妥。

Such a study cannot prove that GLP-1 agonists do not increase the risk of suicidal ideation.

这样研究不能证明GLP-1动不会增加自杀念头风险。

Semaglutide belongs to a class of drugs known as GLP-1 agonists, which were designed to treat type 2 diabetes.

塞马格鲁肽属一类叫做GLP-1动物，该物旨在治疗2型糖尿病。

Ropinirole is from a group of drugs called dopamine agonists.

罗匹尼罗来自一组称为多巴胺动物。

Individuals with more severe forms of asthma might need additional treatments like daily corticosteroids, long-acting beta-adrenoceptor agonists, or leukotriene antagonists.

哮喘较为严重患者可能需要额外治疗，如日服皮质类固醇，施用长效β肾上腺素受体动或白三烯拮抗。

When the agonist contracts upon electrical activation, it stretches the antagonist.

当动因而收缩时，它会拉伸拮抗。

Sulfonylureas, I think they're called, they're PPAR gamma agonists.

我认为它们被称为磺酰脲类物，它们是 PPAR γ 动。

Other researchers are also running studies on GLP-1 agonists and addiction.

其他研究人员也在对GLP-1促效和成瘾进行研究。

One idea to boost efficacy is to combine GLP-1 with other agonists.

提高疗效一个方法是将 GLP-1 与其他动结合起来。

GLP-1 agonists are extremely effective and relatively safe.

GLP-1 动非常有效并且相对安全。

Augmentation and withdrawal from dopamine agonists; it was the most horrendous experience of my life.

多巴胺动增强和戒断；这是我一生中最可怕经历。

The AMI comprises two muscles that are surgically connected, an agonist linked to an antagonist.

AMI 包括两块通过手术连接肌肉，一条与拮抗相连主动肌。

All dopamine agonists may cause nausea, orthostatic hypotension, mental disturbances, and daytime sleepiness.

所有多巴胺动都可能引起恶心、直立性低血压、精神障碍和白天嗜睡。

Both drugs belong to a class of medicines called GLP-1 receptor agonists.

这两种物都属一类被称为胰高血糖素样肽-1受体动物。

Definitely. There are also a lot of questions about whether or not a GLP-1 agonist would be a lifelong addiction treatment.

绝对。还有很多关 GLP-1 动是否会是终身脱瘾治疗问题。

The first GLP-1 receptor agonist came out in 2005 - exenatide - for treatment of Type 2 diabetes.

第一个 GLP-1 受体动 2005 年问世 - 艾塞那肽 - 用治疗 2 型糖尿病。

In 2022, a research group completed the largest trial in humans so far using exenatide, another GLP-1 agonist drug.

2022年，一个研究小组使用另一种GLP-1促效艾塞那肽完成了迄今为止最大规模人体试验。

Semaglutide is a type of GLP-1 agonist, which means that it binds to and activates specific receptors in the body.

Semagrutide是一种GLP-1促效，它能与体内特定受体结合并。